Description

N-Acetyl-Selank Amidate Nasal Spray

N-Acetyl-Selank Amidate
CAS Number	129954-34-3
Molar Mass	751.9g.mol-1
Chemical Formula	C33H57N11O9
IUPAC Name	(2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid

Introduction

introducing BC9’s N-Acetyl-Selank Amidate – a groundbreaking advancement in the realm of research-grade compounds. This revolutionary product is meticulously crafted to elevate research endeavors centered around cognitive and emotional processes. N-Acetyl-Selank Amidate, synonymous with Selank, is a synthetic peptide originating from the naturally occurring peptide tuftsin.

Key Characteristics

These sprays contain N-Acetyl-Selank Amidate, a modified peptide with structural alterations designed to enhance stability and bioavailability for research purposes. The compound is known for its potential impact on various neurochemical pathways.

Research Applications

N-Acetyl-Selank Amidate Sprays are intended for laboratory research applications, offering scientists and researchers a tool to explore the potential effects of this compound on neurochemistry and related areas.

Research Benefits

May Regulate Stress Response

Numerous research studies suggest that N-Acetyl-Selank Amidate may have the potential to modulate the stress response. Experimental data indicates that this compound could influence the release of stress-related hormones, providing a foundation for further investigations into stress regulation mechanisms.

May Improve Cognitive Enhancement

Research on N-Acetyl-Selank Amidate indicates potential cognitive enhancement properties. Studies suggest that the compound may influence cognitive functions such as memory and learning, making it a subject of interest for researchers exploring novel avenues for cognitive improvement.

Plausible Anxiolytic Effects

Preliminary research suggests that N-Acetyl-Selank Amidate may exhibit anxiolytic effects in experimental models. Investigations indicate a potential modulation of neurotransmitters associated with anxiety, providing a basis for further exploration of its anxiolytic properties.

Summary

In summary, N-Acetyl-Selank Amidate Nasal Sprays is a research product developed exclusively for scientific investigations. The modified peptide within these sprays holds promise for research into stress regulation, cognitive enhancement, and anxiolytic effects. Researchers are encouraged to explore the potential applications of this compound within the confines of ethical and scientific research practices, avoiding any implications for human consumption.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Zozulia AA, Neznamov GG, Siuniakov TS, Kost NV, Gabaeva MV, Sokolov OIu, Serebriakova EV, Siranchieva OA, Andriushenko AV, Telesheva ES, Siuniakov SA, Smulevich AB, Miasoedov NF, Seredenin SB. [Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia]. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38-48. Russian. PMID: 18454096. [Read More]
2. Semenova TP, Kozlovskiĭ II, Zakharova NM, Kozlovskaia MM. [Experimental optimization of learning and memory processes by selank]. Eksp Klin Farmakol. 2010 Aug;73(8):2-5. Russian. PMID: 20919548. [Read More]
3. Zozulya AA, Kost NV, Yu Sokolov O, Gabaeva MV, Grivennikov IA, Andreeva LN, Zolotarev YA, Ivanov SV, Andryushchenko AV, Myasoedov NF, Smulevich AB. The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity. Bull Exp Biol Med. 2001 Apr;131(4):315-7. doi: 10.1023/a:1017979514274. PMID: 11550013. [Read More]